Status of serum VEGF and ICAM-1 and its association with external limiting membrane and inner segment-outer segment junction disruption in type 2 diabetes mellitus

Molecular Vision

Volumn 19, Issue , 2013, Pages 1760-1767

  Jain, Astha ^a   Saxena, Sandeep ^a   Khanna, Vinay K ^b   Shukla, Rajendra K ^b   Meyer, Carsten H ^c  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^c Klinik Pallas   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INTERCELLULAR ADHESION MOLECULE 1; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE SEVERITY; EXTERNAL LIMITING MEMBRANE DAMAGE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MACULAR THICKNESS; MAJOR CLINICAL STUDY; MALE; MEMBRANE DAMAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; NON PROLIFERATIVE DIABETIC RETINOPATHY; PATHOGENESIS; PHOTORECEPTOR INNER SEGMENT; PHOTORECEPTOR OUTER SEGMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TERTIARY HEALTH CARE; VISUAL ACUITY;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; RETINAL PHOTORECEPTOR CELL INNER SEGMENT; RETINAL PHOTORECEPTOR CELL OUTER SEGMENT; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84881249976     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Chowdhury TA, Hopkins D, Dodson PM, Vafidis GC. The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy? Eye (Lond) 2002; 16:689-93. [PMID: 12439660].
2. Joussen AM, Poulaki V, Qin W, Kirchhof B. Mitsiades Nicholas, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis AP. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesionin vivo. Am J Pathol 2002; 160:501-9. [PMID: 11839570].
3. Otani T, Yamaguchi Y, Kishi S. Correlation between visual acuity and foveal microstructural changes indiabeticmacular edema. Retina 2010; 30:774-80. [PMID: 19996821].
4. Shin HJ, Lee SH, Chung H, Kim HC. Association between photoreceptor integrity and visual outcome in diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 2012; 250:61-70. [PMID: 21874345].
5. van de Stolpe A, van der Saag PT. Intercellular adhesion molecule-1. J Mol Med (Berl) 1996; 74:13-33. [PMID: 8834767].
6. Meleth AD, Agrón E, Chan CC, Reed GF, Arora K, Byrnes G, Csaky KG, Ferris FL III, Chew EY. Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci 2005; 46:4295-301. [PMID: 16249511].
7. Miyamoto K, Khosrof S, Bursell SE, Rohan R, Murata T, Clermont A, Aiello LP, Ogura Y, Adamis AP. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci USA 1999; 96:10836-41. [PMID: 10485912].
8. Joussen AM, Murata T, Tsujikawa A, Kirchhof B, Bursell SE, Adamis AP. Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am J Pathol 2001; 158:147-52. [PMID: 11141487].
9. Zhang XL, Wen L, Chen YJ, Zhu Y. Vascular endothelial growth factor up-regulates the expression of intracellular adhesion molecule-1 in retinal endothelial cells via reactive oxygen species, but not nitric oxide. Chin Med J (Engl) 2009; 122:338-43. [PMID: 19236815].
10. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling-in control of vascular function. Nat Rev Mol Cell Biol 2006; 7:359-71. [PMID: 16633338].
11. Crawford TN, Alfaro DV, Kerrison JB, Jablon EP. Diabetic retinopathy and angiogenesis. Curr Diabetes Rev 2009; 5:8-13. [PMID: 19199892].
12. Funatsu H, Yamashita H, Noma H, Shimizu E, Yamashita T, Hori S. Stimulation and inhibition of angiogenesis in diabetic retinopathy. Jpn J Ophthalmol 2001; 45:577-84. [PMID: 11754898].
13. Drexler W, Sattmann H, Hermann B, Ko TH, Stur M, Unterhuber A, Scholda C, Findl O, Wirtitsch M, Fujimoto JG, Fercher AF. Enhanced visualization of macular pathology with the use of ultrahighresolution optical coherence tomography. Arch Ophthalmol 2003; 121:695-706. [PMID: 12742848].
14. Srinivasan VJ, Monson BK, Wojtkowski M, Bilonick RA, Gorczynska I, Chen R, Duker JS, Schuman JS, Fujimotoet JG. Characterization of outer retinal morphology with high-speed, ultrahighresolution optical coherence tomography. Invest Ophthalmol Vis Sci 2008; 49:1571-9. [PMID: 18385077].
15. Kevany BM, Palczewski K. Phagocytosis of retinal rod and cone photoreceptors. Physiology (Bethesda) 2010; 25:8-15. [PMID: 20134024].
16. Sakamoto A, Nishijima K, Kita M, Oh H, Tsujikawa A, Yoshimura N. Association between foveal photoreceptor status and visual acuity after resolution of diabetic macular edema by pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol 2009; 247:1325-30. [PMID: 19430805].
17. Early treatment diabetic retinopathy study research group. Grading diabetic retinopathy from stereoscopic color fundus photographs. ETDRS report number 10. Ophthalmology 1991; 98:786-806. [PMID: 2062513].
18. Mohan N, Monickaraj F, Balasubramanyam M, Rema M, Mohan V. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferativediabetic retinopathy. J Diabetes Complications 2012; 26:435-41. [PMID: 22699109].
19. Nikitina VV, Zakharova NB, Kamenskikh TG. Roleof vascular endothelial growth factor and monocyte chemoattractant protein-1 in the development of endothelial dysfunction in types 1 & 2 diabetes mellitus complicated bydiabetic retinopathy. Klin Lab Diagn 2011; 6:8-10. [PMID: 21851000].
20. Baharivand N, Zarghami N, Panahi F, Dokht Ghafari MY, Mahdavi Fard A, Mohajeri A. Relationship between vitreous and serum vascular endothelial growth factor levels, control of diabetes and microalbuminuria in proliferative diabetic retinopathy. Clin Ophthalmol. 2012; 6:185-91. [PMID: 22331976].
21. Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, Schraermeyer U, Kociok N, Fauser S, Kirchhof B, Kern TS, Adamis AP. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 2004; 18:1450-2. [PMID: 15231732].
22. Nowak M, Wielkoszyński T, Marek B, Kos-Kudła B, Świe{ogonek}tochowska E, Siemińska L, Kajdaniuk D, Głogowska-Szelag J, Nowak K. Blood serum levels of vascular cell adhesion molecule (sVCAM-1), intercellular adhesion molecule (sICAM-1) and endothelial leucocyte adhesion molecule-1 (ELAM-1) in diabetic retinopathy Clin Exp Med 2008; 8:159-64. [PMID: 18791689].
23. Adamiec-Mroczek J, Oficjalska-Młyńczak J, Misiuk-Hojło M. Proliferative diabetic retinopathy-The influence of diabetes control on the activation of the intraocular molecule system. Diabetes Res Clin Pract 2009; 84:46-50. [PMID: 19237221].
24. Hernández C, Burgos R, Canton A, Arumi JG, Segura RM, Simo R. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Diabetes Care 2001; 24:516-21. [PMID: 11289478].
25. Lu M, Perez VL, Ma N, Miyamoto K, Peng HB, Liao JK, Adamis AP. VEGF Increases Retinal Vascular ICAM-1 Expression In Vivo. Invest Ophthalmol Vis Sci 1999; 40:1808-12. [PMID: 10393052].
26. Tolentino MJ, Miller JW, Gragoudas ES. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 1996; 103:1820-8. [PMID: 8942877].
27. Lu M, Perez VL, Ma N, Miyamoto K, Peng HB, Liao JK, Adamis AP. VEGF Increases Retinal Vascular ICAM-1 Expression In Vivo. Invest Ophthalmol Vis Sci 1999; 40:1808-12. [PMID: 10393052].
28. Miyamoto K, Khosrof S, Bursell SE, Moromizato Y, Aiello LP, Ogura Y, Adamis AP. Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). Am J Pathol 2000; 156:1733-9. [PMID: 10793084].
29. Yamada H, Yamada E, Hackett SF, Ozaki H, Okamoto N, Campochiaro PA. Hyperoxia causes decreased expression of vascular endothelial growth factor and endothelial cell apoptosis in adult retina. J Cell Physiol 1999; 179:149-56. [PMID: 10199554].
30. Omri S, Omri B, Savoldelli M, Jonet L, Thillaye-Goldenberg B, Thuret G, Gain P, Jeanny JC, Behar-Cohen F. The outer limiting membrane (OLM) revisited: clinical implications. Clin Ophthalmol. 2010; 4:183-95. [PMID: 20463783].
31. Mehalow AK, Kameya S, Smith RS, Hawes NL, Denegre JM, Young JA, Bechtold L, Haider NB, Tepass U, Heckenlively JR, Chang B, Naggert JK, Nishina PM. CRB1 is essential for external limiting membrane integrity and photoreceptor morphogenesis in the mammalian retina. Hum Mol Genet 2003; 12:2179-89. [PMID: 12915475].
32. Murakami T, Nishijima K, Akagi T, Uji A, Horii T, Ueda-Arakawa N, Muraoka Y, Yoshimura N. Optical coherence tomographic reflectivity of photoreceptors beneath cystoid spaces in diabetic macular edema. Invest Ophthalmol Vis Sci 2012; 53:1506-11. [PMID: 22323463].
33. Chhablani JK, Kim JS, Cheng L, Kozak I, Freeman W. Externallimitingmembraneas a predictor of visual improvement in diabetic macular edema after pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol 2012; 250:1415-20. [PMID: 22354371].
34. Ito S, Miyamoto N, Ishida K, Kurimoto Y. Association between external limiting membrane status and visual acuity in diabetic macular oedema. Br J Ophthalmol 2013; 97:228-32. [PMID: 23172879].
35. Yamauchi Y, Yagi H, Usui Y, Kimura K, Agawa T, Tsukahara R, Yamakawa N, Goto H. Biological activity is the likely origin of the intersection between the photoreceptor inner and outer segments of the rat retina as determined byoptical coherence tomography. Clin Ophthalmol. 2011; 5:1649-53. [PMID: 22174571].